Adverse drug events in hospitalized patients treated with cardiovascular drugs and anticoagulants

Pharmacoepidemiology and Drug Safety

Volumn 11, Issue 3, 2002, Pages 235-238

  Zaidenstein, R ^a,b   Eyal, S ^a   Efrati, S ^a,b   Akivison, L ^a   Michowitz, M Koren ^a,b   Nagornov, V ^a,b   Golik, A ^a,b  

^a ASSAF HAROFEH MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

ADEs; Cardiovascular drugs; Hospitalized patients; Pharmacovigilance

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; AMLODIPINE; ANTICOAGULANT AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CARDIOVASCULAR AGENT; CILAZAPRIL; DIGOXIN; DILTIAZEM; DIURETIC AGENT; FUROSEMIDE; HYDROCHLOROTHIAZIDE; ISOSORBIDE MONONITRATE; NITRATE; PROPAFENONE; SPIRONOLACTONE; UREA; WARFARIN;

ACUTE HEPATITIS; ACUTE KIDNEY FAILURE; ADULT; AGED; ALGORITHM; ARTICLE; BLEEDING; BRADYCARDIA; CONTROLLED STUDY; DISEASE COURSE; DRUG HYPERSENSITIVITY; DRUG SURVEILLANCE PROGRAM; ECONOMIC ASPECT; FEMALE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HIGH RISK PATIENT; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; HYPERTENSION; INCIDENCE; INTERNAL MEDICINE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; ORTHOSTATIC HYPOTENSION; PARANOIA; PRIORITY JOURNAL; SKIN NECROSIS; UREA BLOOD LEVEL; UREMIA; HOSPITAL INFORMATION SYSTEM; IATROGENIC DISEASE; MIDDLE AGED;

ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; CARDIOVASCULAR AGENTS; FEMALE; HOSPITAL INFORMATION SYSTEMS; HOSPITALIZATION; HUMAN; IATROGENIC DISEASE; MALE; MIDDLE AGE; HUMANS; MIDDLE AGED;

EID: 0036001106     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/pds.693     Document Type: Article

References (20)

1. The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II
2. Adverse drug reactions: A critical review
3. Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies
4. Incidence and costs of adverse drug reactions during hospitalization: Computerised monitoring versus stimulated spontaneous reporting
5. The costs of adverse drug events in hospitalized patients
6. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality
7. Incidence of adverse drug events and potential adverse drug events. Implications for prevention
8. Computerized surveillance of adverse drug events in hospital patients
9. Iatrogenic illness on a general medical service at a university hospital
10. Hospital admissions due to adverse drug reactions: A comparative study from Jerusalem and Berlin
11. A method for estimating the probability of adverse drug reactions
12. The costs of adverse drug events in hospitalized patients
13. Computerized surveillance of adverse drug reactions in hospital: Implementation
14. Cardiovascular pharmacology of aging
15. Preventing adverse drug events in hospitalized patients
16. Retrospective analysis of the frequency and recognition of adverse drug reactions by means of automatically recorded laboratory signals
17. Frequency, consequences and prevention of adverse drug events
18. Algorithms used in adverse drug event reports: A comparative study
19. The application of adverse drug reactions data to drug choice decisions